1. Temsirolimus Enhances Anti-Cancer Immunity by Inducing Autophagy-Mediated Degradation of the Secretion of Small Extracellular Vesicle PD-L1
    Seong-Sik Park et al, 2022, Cancers CrossRef
  2. A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma
    Dylan B. Ness et al, 2023, Cancer Medicine CrossRef
  3. Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma
    Siwei Yang et al, 2024, Heliyon CrossRef